Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma

BACKGROUND: Anti-PD-1 and BRAF-inhibitors (BRAFi) have been approved as first-line treatments in advanced melanoma. To date, no prospective data are available to give the best sequence of treatment. The objective of this study was to evaluate in real-life the efficacy of anti-PD-1 after BRAFi, ipili...

Descripción completa

Detalles Bibliográficos
Autores principales: Amini-Adle, M., Khanafer, N., Le-Bouar, M., Duru, G., Dalle, S., Thomas, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029356/
https://www.ncbi.nlm.nih.gov/pubmed/29970025
http://dx.doi.org/10.1186/s12885-018-4618-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029356/
https://www.ncbi.nlm.nih.gov/pubmed/29970025
http://dx.doi.org/10.1186/s12885-018-4618-9

Ejemplares similares